Copyright
©The Author(s) 2025.
World J Clin Cases. Aug 6, 2025; 13(22): 106925
Published online Aug 6, 2025. doi: 10.12998/wjcc.v13.i22.106925
Published online Aug 6, 2025. doi: 10.12998/wjcc.v13.i22.106925
Table 3 Comparison of traditional markers and pleural adenosine deaminase for pleural effusion diagnosis
Marker/method | Pros | Cons |
Light’s criteria | Standardized, non-invasive | Low specificity for inflammation etiology (e.g., cannot distinguish TB from cancer) |
LDH | Sensitive for identifying exudates | Not specific to inflammation; influenced by tissue necrosis |
Protein level | Used in Light’s criteria | Less discriminatory than P-ADA for differentiating inflammatory vs transudative effusions |
P-ADA ≥ 9.00 U/L | High specificity and sensitivity for inflammation. Non-invasive and cost-effective | Requires validation across diverse populations. Lacks global consensus on cutoffs |
- Citation: Shi DD, Tian J, Ding J. Adenosine deaminase in pleural effusion: Bridging diagnosis and the pathophysiology of inflammation. World J Clin Cases 2025; 13(22): 106925
- URL: https://www.wjgnet.com/2307-8960/full/v13/i22/106925.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i22.106925